$TBTC
TABLE TRAC INC

2020 Q3 Form 10-Q Financial Statement

#000143774920023520 Filed on November 12, 2020

View on sec.gov

Income Statement

Concept 2020 Q3 2019 Q4 2019 Q3
Revenue $1.189M $1.847M $2.439M
YoY Change -51.26% 31.47% 4.68%
Cost Of Revenue $314.4K $1.111M $448.9K
YoY Change -29.96% 166.1% -22.97%
Gross Profit $874.2K $735.9K $1.990M
YoY Change -56.07% -25.45% 13.91%
Gross Profit Margin 73.55% 39.85% 81.59%
Selling, General & Admin $843.8K $555.7K $1.340M
YoY Change -37.01% -55.86% 20.44%
% of Gross Profit 96.52% 75.51% 67.32%
Research & Development $199.1K $57.04K
YoY Change
% of Gross Profit 27.06% 2.87%
Depreciation & Amortization $9.650K $13.95K $11.88K
YoY Change -18.77% 25.34% -19.29%
% of Gross Profit 1.1% 1.9% 0.6%
Operating Expenses $843.8K $754.8K $1.340M
YoY Change -37.01% -40.04% 20.44%
Operating Profit $30.43K -$18.88K $650.3K
YoY Change -95.32% -93.05% 2.47%
Interest Expense $11.26K $17.38K $10.75K
YoY Change 4.74% 24.77% 3.27%
% of Operating Profit 37.0% 1.65%
Other Income/Expense, Net
YoY Change
Pretax Income $41.70K -$1.490K $661.0K
YoY Change -93.69% -99.42% 2.48%
Income Tax $12.18K -$1.000K $130.0K
% Of Pretax Income 29.22% 19.67%
Net Earnings $29.51K -$490.00 $531.0K
YoY Change -94.44% -99.73% 14.35%
Net Earnings / Revenue 2.48% -0.03% 21.77%
Basic Earnings Per Share $0.01 $0.12
Diluted Earnings Per Share $0.01 -$109.60 $0.12
COMMON SHARES
Basic Shares Outstanding 4.487M 4.494M
Diluted Shares Outstanding 4.495M 4.501M

Balance Sheet

Concept 2020 Q3 2019 Q4 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.955M $1.264M $1.730M
YoY Change 13.01% -2.09% 172.95%
Cash & Equivalents $1.955M $1.264M $1.730M
Short-Term Investments
Other Short-Term Assets $136.0K $380.0K $377.3K
YoY Change -63.96% 30.2% -11.15%
Inventory $1.843M $1.264M $1.413M
Prepaid Expenses $136.0K $380.0K
Receivables $2.118M $2.252M $2.755M
Other Receivables $0.00 $167.7K $0.00
Total Short-Term Assets $6.052M $5.327M $6.274M
YoY Change -3.54% 2.21% 21.94%
LONG-TERM ASSETS
Property, Plant & Equipment $38.86K $74.15K $180.4K
YoY Change -78.47% -14.44% 212.83%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $2.143M $242.9K $1.483M
YoY Change 44.52% -85.24% -18.58%
TOTAL ASSETS
Total Short-Term Assets $6.052M $5.327M $6.274M
Total Long-Term Assets $2.143M $242.9K $1.483M
Total Assets $8.195M $5.570M $7.757M
YoY Change 5.65% -18.77% 11.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $111.3K $367.7K $211.5K
YoY Change -47.36% -5.19% 20.09%
Accrued Expenses $128.9K $98.04K $278.1K
YoY Change -53.63% 185.08% 382.83%
Deferred Revenue $161.2K $253.7K
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Long-Term Debt Due $287.6K $0.00
YoY Change
Total Short-Term Liabilities $695.1K $719.5K $1.247M
YoY Change -44.27% -11.43% 258.32%
LONG-TERM LIABILITIES
Long-Term Debt $185.8K $0.00 $0.00
YoY Change
Other Long-Term Liabilities $2.177M $27.87K $1.471M
YoY Change 48.02% -98.35% -22.75%
Total Long-Term Liabilities $185.8K $0.00 $1.471M
YoY Change -87.36% -100.0% -22.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $695.1K $719.5K $1.247M
Total Long-Term Liabilities $185.8K $0.00 $1.471M
Total Liabilities $3.445M $1.212M $3.167M
YoY Change 8.77% -60.35% 5.47%
SHAREHOLDERS EQUITY
Retained Earnings $3.122M $2.751M
YoY Change
Common Stock $1.874M $1.852M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost) $245.6K $245.6K
YoY Change
Treasury Stock Shares $149.9K $149.9K
Shareholders Equity $4.498M $4.357M $4.590M
YoY Change
Total Liabilities & Shareholders Equity $8.195M $5.570M $7.757M
YoY Change 5.65% -18.77% 11.35%

Cashflow Statement

Concept 2020 Q3 2019 Q4 2019 Q3
OPERATING ACTIVITIES
Net Income $29.51K -$490.00 $531.0K
YoY Change -94.44% -99.73% 14.35%
Depreciation, Depletion And Amortization $9.650K $13.95K $11.88K
YoY Change -18.77% 25.34% -19.29%
Cash From Operating Activities $447.0K -$466.0K $1.610M
YoY Change -72.25% -167.06% -728.73%
INVESTING ACTIVITIES
Capital Expenditures $0.00 $0.00 -$35.45K
YoY Change -100.0% -100.0% 5617.74%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change
Cash From Investing Activities $0.00 $0.00 -$35.45K
YoY Change -100.0% -100.0% 5617.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 0.000 -51.50K
YoY Change -100.0% -100.0% 2199.11%
NET CHANGE
Cash From Operating Activities 447.0K -466.0K 1.610M
Cash From Investing Activities 0.000 0.000 -35.45K
Cash From Financing Activities 0.000 0.000 -51.50K
Net Change In Cash 447.0K -466.0K 1.523M
YoY Change -70.66% -170.93% -688.22%
FREE CASH FLOW
Cash From Operating Activities $447.0K -$466.0K $1.610M
Capital Expenditures $0.00 $0.00 -$35.45K
Free Cash Flow $447.0K -$466.0K $1.646M
YoY Change -72.84% -164.28% -744.13%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 tbtc Accounts Receivable Under Normal30 Day Terms
AccountsReceivableUnderNormal30DayTerms
1250844
CY2019Q4 tbtc Accounts Receivable Under Normal30 Day Terms
AccountsReceivableUnderNormal30DayTerms
1649695
CY2020Q3 tbtc Contract And Other Long Term Assets
ContractAndOtherLongTermAssets
740774
CY2019Q4 tbtc Contract And Other Long Term Assets
ContractAndOtherLongTermAssets
1037364
CY2020Q3 tbtc Percent Of Revenues
PercentOfRevenues
1
CY2019Q3 tbtc Percent Of Revenues
PercentOfRevenues
1
tbtc Percent Of Revenues
PercentOfRevenues
1
tbtc Percent Of Revenues
PercentOfRevenues
1
CY2020Q3 tbtc Revenue Remaining Performance Obligation Collection Threshold Next Twelve Months Percentage
RevenueRemainingPerformanceObligationCollectionThresholdNextTwelveMonthsPercentage
0.67
CY2019Q3 tbtc Stock Repurchased Into Treasury During Period Value
StockRepurchasedIntoTreasuryDuringPeriodValue
51500
CY2020Q3 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
111344
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
367730
CY2020Q3 us-gaap Accounts Receivable Gross
AccountsReceivableGross
3468355
CY2019Q4 us-gaap Accounts Receivable Gross
AccountsReceivableGross
4990182
CY2020Q3 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
915149
CY2019Q4 us-gaap Accounts Receivable Gross Current
AccountsReceivableGrossCurrent
1086820
CY2020Q3 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
1302362
CY2019Q4 us-gaap Accounts Receivable Gross Noncurrent
AccountsReceivableGrossNoncurrent
2253667
CY2020Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
3420732
CY2019Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
4791559
CY2020Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2118370
CY2019Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2537892
us-gaap Cost Of Revenue
CostOfRevenue
935422
us-gaap Cost Of Revenue
CostOfRevenue
1577328
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-156000
CY2020Q3 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
1302362
CY2019Q4 us-gaap Accounts Receivable Net Noncurrent
AccountsReceivableNetNoncurrent
2253667
CY2020Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6063
CY2019Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
0
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1869626
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1847594
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
198623
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
165840
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
47623
CY2020Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
47623
CY2019Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
198623
us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
34378
CY2019 us-gaap Allowance For Doubtful Accounts Receivable Period Increase Decrease
AllowanceForDoubtfulAccountsReceivablePeriodIncreaseDecrease
115000
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
185378
CY2019 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
82217
CY2020Q3 us-gaap Assets
Assets
8195291
CY2019Q4 us-gaap Assets
Assets
9056000
CY2020Q3 us-gaap Assets Current
AssetsCurrent
6052467
CY2019Q4 us-gaap Assets Current
AssetsCurrent
5612898
CY2020Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
2142824
CY2019Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3443102
CY2020Q3 us-gaap Cash
Cash
1954885
CY2019Q4 us-gaap Cash
Cash
1263762
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1263762
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1290797
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1954885
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1729795
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
691123
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
438998
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
25000000
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4656734
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
4506788
CY2020Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4656734
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
4506788
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
4507
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
4507
CY2020Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
161234
CY2019Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
253709
CY2020Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
2164580
CY2019Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
3148410
CY2020Q3 us-gaap Cost Of Revenue
CostOfRevenue
349998
CY2019Q3 us-gaap Cost Of Revenue
CostOfRevenue
448885
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
980753
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
42432
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
9200
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
15721
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-106000
CY2020Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
387000
CY2019Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
543000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
35292
us-gaap Depreciation And Amortization
DepreciationAndAmortization
33996
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.12
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.18
CY2020Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
76704
CY2019Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
44500
CY2020Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
36720
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
0
us-gaap Gain Loss On Disposition Of Assets1
GainLossOnDispositionOfAssets1
25713
CY2020Q3 us-gaap Gross Profit
GrossProfit
938561
CY2019Q3 us-gaap Gross Profit
GrossProfit
1989934
us-gaap Gross Profit
GrossProfit
2873064
us-gaap Gross Profit
GrossProfit
4484460
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
100161
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
661035
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
133747
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21300
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
130000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22500
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
175000
CY2020Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
0
CY2019Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
167673
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-273351
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-216781
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1279198
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-117751
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1076305
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-28479
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
32204
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
188027
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-173736
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-184700
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
579649
CY2020Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2019Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
0
CY2020Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
680
CY2019Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
7742
CY2020Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
5381
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
10752
us-gaap Investment Income Interest
InvestmentIncomeInterest
74758
us-gaap Investment Income Interest
InvestmentIncomeInterest
39064
CY2020Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.05
CY2020Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
67353
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
650547
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-557690
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-66237
CY2020Q3 us-gaap Inventory Net
InventoryNet
1843238
CY2019Q4 us-gaap Inventory Net
InventoryNet
1263589
CY2020Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
2914
CY2020Q3 us-gaap Liabilities
Liabilities
3444766
CY2019Q4 us-gaap Liabilities
Liabilities
4438754
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8195291
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
9056000
CY2020Q3 us-gaap Liabilities Current
LiabilitiesCurrent
695148
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
719477
CY2020Q3 us-gaap Long Term Debt
LongTermDebt
473400
CY2020Q3 us-gaap Long Term Debt Current
LongTermDebtCurrent
287582
CY2019Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
77922
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
287582
CY2020Q3 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
185818
CY2020Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
185818
CY2019Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
473400
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-53721
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28445
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
217723
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
521164
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
7955
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
266763
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
531035
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-1188
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
33574
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
78861
us-gaap Net Income Loss
NetIncomeLoss
111247
us-gaap Net Income Loss
NetIncomeLoss
805753
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
78861
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
531035
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
111247
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
805753
us-gaap Notes Issued1
NotesIssued1
800
us-gaap Notes Issued1
NotesIssued1
800
us-gaap Open Tax Year
OpenTaxYear
2016 2017 2018 2019
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
94780
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
650283
us-gaap Operating Income Loss
OperatingIncomeLoss
58989
us-gaap Operating Income Loss
OperatingIncomeLoss
941689
CY2020Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
15333
us-gaap Operating Lease Cost
OperatingLeaseCost
46824
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
64439
CY2020Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
52221
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
53538
CY2020Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
12218
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
27867
us-gaap Operating Lease Payments
OperatingLeasePayments
46824
us-gaap Operating Lease Payments
OperatingLeasePayments
46367
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
60831
CY2020Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y102D
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
51500
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
0
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
35445
CY2020Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
135974
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
379982
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
473400
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
0
us-gaap Proceeds From Sale Of Finance Receivables
ProceedsFromSaleOfFinanceReceivables
7000
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
38857
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
74149
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
91629
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
115000
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
2221
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55522
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
73044
CY2020Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7344
CY2020Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7344
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
3798736
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
3819098
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
4098266
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
4590207
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
4617246
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
4623402
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
4664320
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3122023
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
3010776
CY2020Q3 us-gaap Revenues
Revenues
1288559
CY2019Q3 us-gaap Revenues
Revenues
2438819
us-gaap Revenues
Revenues
3808486
us-gaap Revenues
Revenues
6061788
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
843781
CY2019Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1339651
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2814075
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3542771
us-gaap Share Based Compensation
ShareBasedCompensation
22032
us-gaap Share Based Compensation
ShareBasedCompensation
37218
CY2020Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12407
CY2019Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12405
CY2019Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
12406
CY2020Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
7344
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
4750525
CY2020Q3 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
4996156
CY2019Q4 us-gaap Stockholders Equity Before Treasury Stock
StockholdersEquityBeforeTreasuryStock
4862877
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
149946
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
149946
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
245631
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
245631
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><div style="display: inline; text-decoration: underline;">Use of Estimates</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles (GAAP) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. The Company's use of estimates and assumptions include: for revenue recognition, determining the nature and timing of satisfaction of performance obligations, and determining the standalone selling price (&#x201c;SSP&#x201d;) of performance obligations, variable consideration, and other obligations, realizability of accounts receivable, the valuation of deferred tax assets and liabilities, deferred revenue and costs, and inventory valuation. Actual results could differ from those estimates, and the difference could be significant.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">&nbsp;</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The Company's significant accounting policies are described in Note <div style="display: inline; font-style: italic; font: inherit;">1</div> of the financial statement included in its Annual Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline;"><div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019</div></div>.</div></div></div>
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4494758
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4500862
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4495569
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
4503138
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4486788
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4493777
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4486788
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
4497435

Files In Submission

Name View Source Status
0001437749-20-023520-index-headers.html Edgar Link pending
0001437749-20-023520-index.html Edgar Link pending
0001437749-20-023520.txt Edgar Link pending
0001437749-20-023520-xbrl.zip Edgar Link pending
ex_200996.htm Edgar Link pending
ex_200997.htm Edgar Link pending
ex_200998.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tbltrc20200930_10q.htm Edgar Link pending
tbtc-20200930.xml Edgar Link completed
tbtc-20200930.xsd Edgar Link pending
tbtc-20200930_cal.xml Edgar Link unprocessable
tbtc-20200930_def.xml Edgar Link unprocessable
tbtc-20200930_lab.xml Edgar Link unprocessable
tbtc-20200930_pre.xml Edgar Link unprocessable